Stocks
Harmony Biosciences Holdings, Inc.HRMY
NASDAQHealthcareBiotechnology$36.13
Price as of · delayed, not real-time
A commercial-stage biopharmaceutical company focused on rare neurological disorders, with its lead product, a treatment for narcolepsy, already on the market. Its pipeline includes additional sleep and neuropsychiatric candidates, and investors track it for its revenue growth and regulatory milestones.
52W Range: $25.90-$43.49
Congressional Interest in Harmony Biosciences Holdings, Inc. (HRMY)
No congressional trades have been disclosed for Harmony Biosciences Holdings, Inc. (HRMY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HRMY?
No congressional trades found for this stock.